Predicted heart mass is the optimal metric for size match in heart transplantation.


Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
02 2019
Historique:
received: 15 05 2018
revised: 18 09 2018
accepted: 19 09 2018
pubmed: 12 12 2018
medline: 17 3 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

Donor-recipient size match is traditionally assessed by body weight. We assessed the ability of 5 size match metrics-predicted heart mass (PHM), weight, height, body mass index (BMI) and body surface area (BSA)-to predict 1-year mortality after heart transplant and to assess the effect of size match on donor heart turn down for size. The study cohort comprised 19,168 adult heart transplant recipients in the United Network for Organ Sharing registry between 2007 and 2016. Each size match metric was divided into 7 equally sized groups using the donor-recipient ratio for each metric. Single and multivariable Cox proportional hazard models for mortality 1 year after transplant were constructed. Recipients in the severely (donor-recipient PHM ratio 0.54-0.86) undersized group for PHM experienced increased mortality, with a hazard ratio of 1.34 (95% confidence interval, 1.13-1.59; p < 0.001). There was no increased risk of death at 1 year if donors were undersized for weight, height, BMI, or BSA. We found that 32% of heart offers turned down for donor size would be acceptable using a PHM threshold of 0.86 or greater and that 14% of offers accepted (most of which are female donor to male recipient) were below this threshold. PHM is the optimal donor-recipient size match metric for prediction of mortality after heart transplant. Many offers turned down for donor size were above the threshold for adequacy of size match by PHM identified, and thus, the use of PHM could improve donor heart utilization and post-transplant survival.

Sections du résumé

BACKGROUND
Donor-recipient size match is traditionally assessed by body weight. We assessed the ability of 5 size match metrics-predicted heart mass (PHM), weight, height, body mass index (BMI) and body surface area (BSA)-to predict 1-year mortality after heart transplant and to assess the effect of size match on donor heart turn down for size.
METHODS
The study cohort comprised 19,168 adult heart transplant recipients in the United Network for Organ Sharing registry between 2007 and 2016. Each size match metric was divided into 7 equally sized groups using the donor-recipient ratio for each metric. Single and multivariable Cox proportional hazard models for mortality 1 year after transplant were constructed.
RESULTS
Recipients in the severely (donor-recipient PHM ratio 0.54-0.86) undersized group for PHM experienced increased mortality, with a hazard ratio of 1.34 (95% confidence interval, 1.13-1.59; p < 0.001). There was no increased risk of death at 1 year if donors were undersized for weight, height, BMI, or BSA. We found that 32% of heart offers turned down for donor size would be acceptable using a PHM threshold of 0.86 or greater and that 14% of offers accepted (most of which are female donor to male recipient) were below this threshold.
CONCLUSIONS
PHM is the optimal donor-recipient size match metric for prediction of mortality after heart transplant. Many offers turned down for donor size were above the threshold for adequacy of size match by PHM identified, and thus, the use of PHM could improve donor heart utilization and post-transplant survival.

Identifiants

pubmed: 30528987
pii: S1053-2498(18)31664-4
doi: 10.1016/j.healun.2018.09.017
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-165

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Evan P Kransdorf (EP)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: evan.kransdorf@cshs.org.

Michelle M Kittleson (MM)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Lillian R Benck (LR)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Jignesh K Patel (JK)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Joshua S Chung (JS)

Division of Cardiac Surgery, Cedars-Sinai Medical Center, Los Angeles, California.

Fardad Esmailian (F)

Division of Cardiac Surgery, Cedars-Sinai Medical Center, Los Angeles, California.

Brenda L Kearney (BL)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

David H Chang (DH)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Danny Ramzy (D)

Division of Cardiac Surgery, Cedars-Sinai Medical Center, Los Angeles, California.

Lawrence S C Czer (LSC)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Jon A Kobashigawa (JA)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH